Enterprise Financial Services Corp Biogen Inc. Transaction History

Enterprise Financial Services Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $10,753 - $14,023	-38 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $65,009 - $104,092	-251 Reduced 86.85%	38 $13,000
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $8,503 - $9,962	35 Added 13.78%	289 $81,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $49,378 - $74,326	-209 Reduced 45.14%	254 $62,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $2,118 - $2,445	-8 Reduced 1.7%	463 $131,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $1,075 - $1,364	-4 Reduced 0.84%	471 $149,000
Q4 2019 Jan 28, 2020	BUY	$220.06 - $304.07 $660 - $912	3 Added 0.64%	475 $141,000
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $5,218 - $5,853	-24 Reduced 4.84%	472 $110,000
Q2 2019 Jul 30, 2019	SELL	$219.29 - $241.72 $72,146 - $79,525	-329 Reduced 39.88%	496 $116,000
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $11,919 - $18,642	-55 Reduced 6.25%	825 $195,000
Q4 2018 Jan 25, 2019	BUY	$278.5 - $352.75 $4,177 - $5,291	15 Added 1.73%	880 $265,000
Q3 2018 Oct 26, 2018	SELL	$293.51 - $383.83 $17,610 - $23,029	-60 Reduced 6.49%	865 $306,000
Q2 2018 Jul 27, 2018	SELL	$257.52 - $306.91 $4,120 - $4,910	-16 Reduced 1.7%	925 $268,000
Q1 2018 Apr 27, 2018	BUY	$260.13 - $367.91 $6,503 - $9,197	25 Added 2.73%	941 $258,000
Q4 2017 Jan 26, 2018	SELL	$307.64 - $344.58 $2,768 - $3,101	-9 Reduced 0.97%	916 $292,000
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $260,063 - $304,963	925	925 $290,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.